TY  - JOUR 
AU  - Anguita-Ruiz, Augusto
AU  - Pastor-Villaescusa, Belén
AU  - Gil Hernández, Ángel
AU  - Aguilera García, Concepción María
PY  - 2019
UR  - http://hdl.handle.net/10481/57638
AB  - Metformin is a first-line oral antidiabetic agent that has shown additional effects in treating obesity and metabolic syndrome. Inter-individual variability in metformin response could be partially explained by the genetic component. Here, we aimed to...
LA  - eng
PB  - MDPI
KW  - Metformin
KW  - Obesity
KW  - Pediatrics
KW  - SNP
KW  - Pharmacogenetics
KW  - Clinical trials
TI  - Common Variants in 22 Genes Regulate Response to Metformin Intervention in Children with Obesity: A Pharmacogenetic Study of a Randomized Controlled Trial
DO  - 10.3390/jcm8091471
ER  -